204 related articles for article (PubMed ID: 12657125)
1. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma.
Huang HJ; Chang TC; Hong JH; Tseng CJ; Chou HH; Huang KG; Lai CH
Int J Gynecol Cancer; 2003; 13(2):204-11. PubMed ID: 12657125
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer.
Chang TC; Lai CH; Hong JH; Hsueh S; Huang KG; Chou HH; Tseng CJ; Tsai CS; Chang JT; Lin CT; Chang HH; Chao PJ; Ng KK; Tang SG; Soong YK
J Clin Oncol; 2000 Apr; 18(8):1740-7. PubMed ID: 10764435
[TBL] [Abstract][Full Text] [Related]
3. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H
Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759
[TBL] [Abstract][Full Text] [Related]
5. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial.
Napolitano U; Imperato F; Mossa B; Framarino ML; Marziani R; Marzetti L
Eur J Gynaecol Oncol; 2003; 24(1):51-9. PubMed ID: 12691318
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
Stehman FB; Ali S; Keys HM; Muderspach LI; Chafe WE; Gallup DG; Walker JL; Gersell D
Am J Obstet Gynecol; 2007 Nov; 197(5):503.e1-6. PubMed ID: 17980189
[TBL] [Abstract][Full Text] [Related]
7. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
8. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
[TBL] [Abstract][Full Text] [Related]
9. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
10. Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma.
Mossa B; Mossa S; Corosu L; Marziani R
Eur J Gynaecol Oncol; 2010; 31(5):497-503. PubMed ID: 21061788
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results.
Sardi JE; Giaroli A; Sananes C; Ferreira M; Soderini A; Bermudez A; Snaidas L; Vighi S; Gomez Rueda N; di Paola G
Gynecol Oncol; 1997 Oct; 67(1):61-9. PubMed ID: 9345358
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
15. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
16. Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy.
Linghu H; Xu XR; Mei YY; Tang JY; Tang LD; Sun T
Chin Med Sci J; 2004 Jun; 19(2):116-9. PubMed ID: 15250247
[TBL] [Abstract][Full Text] [Related]
17. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables.
Seoud M; Geara FB; Shamseddine A; Salem Z; Khalil A
Eur J Gynaecol Oncol; 2003; 24(2):163-8. PubMed ID: 12701970
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J
J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy in bulky stage IB-IIA cervical cancer: results of a quick course with vincristine, bleomycin, and cisplatin.
Ki KD; Song DH; Tong SY; Lim MC; Lee JM; Lee SK
Int J Gynecol Cancer; 2009 Jan; 19(1):50-3. PubMed ID: 19258941
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
